Minal Mehta, MD
Obstetrics & Gynecology · Fountain Valley, CANPI 1780787580
Payments from drug & device makers
Across 140 payments — averaging $69.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Sumitomo Pharma America, Inc.$256
- Organon$244
- Astellas Pharma US Inc$200
- Myovant Sciences Inc.$151
- Therapeuticsmd, Inc.$145
- plus $651 from 13 others
What the payments were for
- Speaking & faculty fees$6,37566%
- Travel & lodging$60%
- Food & beverage$3,18933%
- Education$1301%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 65 | $8,054 |
| Sumitomo Pharma America, Inc. | 14 | $256 |
| Organon | 7 | $244 |
| Astellas Pharma US Inc | 5 | $200 |
| Myovant Sciences Inc. | 7 | $151 |
| Therapeuticsmd, Inc. | 8 | $145 |
| Hologic Sales And Service, LLC | 7 | $117 |
| Mayne Pharma Commercial LLC | 4 | $96 |
| Coopersurgical, Inc. | 4 | $79 |
| Avion Pharmaceuticals | 5 | $77 |
| Merck | 4 | $66 |
| Exeltis, USA Inc. | 2 | $47 |
| AMAG Pharmaceuticals, Inc. | 2 | $45 |
| Biogen | 1 | $28 |
| Acella Pharmaceuticals, LLC | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Pfizer | 1 | $21 |
| Medicem Inc. | 1 | $16 |
| Convatec Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,700 in reported general payments places this provider in the 90th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 25 | $1,438 |
| Estradiol | 30 | $1,372 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Fountain Valley
- Peyman BanooniBeverly Hills$9.2M
- Vellore BhupathyWhittier$4.3M
- Edwin RamirezOxnard$3.5M
- Nam TranSan Francisco$3M
- Dmitriy RomanenkoSouth Gate$2.7M
- Anita NelsonTorrance$2.1M
- Oleg BessLos Angeles$1.7M
- Rovena ReaganSan Diego$1.7M
- Dana Shippdel Mar$1.7M
- Vanessa JacobySan Francisco$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.